B·R·A·H·M·S PCT assays have been demonstrated to
improve the accuracy of diagnosis and risk assessment in bacterial infection and sepsis1 and to guide antibiotic therapy-related decisions2. PCT cut-offs and clinical algorithms were established by use of B·R·A·H·M·S PCT sensitive KRYPTOR assay which is the global reference standard
- For safe use of these cut-offs and algorithms with other PCT assays it is important to verify that these assays will provide the same result
- The most important criteria for the comparative performance are:
- High correlation to reference
- High assay sensitivity and precision
- High concordance at clinically relevant cut-offs
All B·R·A·H·M·S PCT assays use original raw material from B·R·A·H·M·S GmbH, are calibrated on the same standard and offer excellent correlation and concordance at the established clinical cut-offs.
B·R·A·H·M·S PCT - Secured clinical decision making independent of the platform
 |
B·R·A·H·M·S PCT sensitive KRYPTOR |
|
CE marked / FDA 510(k) cleared |
 |
CE marked | ||
 |
CE marked | ||
|
CE marked / FDA 510(k) cleared | ||
 |
 |
CE marked |
|
 |
VIDAS B·R·A·H·M·S PCT | |
CE marked / FDA 510(k) cleared |
 |
LIAISON B·R·A·H·M·S PCT | |
CE marked / FDA 510(k) cleared |
 |
Lumipulse B·R·A·H·M·S PCT | |
CE marked / FDA 510(k) cleared |
 |
ELECSYS B·R·A·H·M·S PCT | |
CE marked / FDA 510(k) cleared |
 |
Samsung IB B·R·A·H·M·S PCT | |
CE marked |
 |
ADVIA Centaur B·R·A·H·M·S PCT ATELLICA IM B·R·A·H·M·S PCT |
|
CE marked |
| Automated sensitive assay |
Point of care test |
Manual assay |
1. Soni N.J. et al., J Hosp Med 2013;8 (9): 530-40.
2. Meisner, M., Procalcitonin – Biochemistry and Clinical Diagnosis, UNI-MED (Bremen) 2010; ISBN 978-3-8374-1241-3.
